Research and Clinical Study


Johnson & Johnson Surgical Vision ATHENA - Clinical Investigation of the TECNIS® Intraocular Lens, Models C1V000 and C2V000 The purpose of this 6-month clinical study is for regulatory and market launch support of the nextgeneration TECNIS® EDF IOL. Two investigational lenses, Models C1V000 and C2V000, will be evaluated against one control IOL, Model ICB00.
Alcon Research Ltd Clinical Evaluation Following Use of SYSTANE® BALANCE in Subjects with Lipid-Deficient Dry Eye The purpose of this study is to evaluate the clinical effectiveness of SYSTANE BALANCE compared to REFRESH OPTIVE Advanced in patients with dry eye associated with lipid deficiency.
Oculentis Stability of Lens Position of the LaserLens LB-313 after Femtolaser-Assisted Capsulotomy. An International Multicentered Study The purpose of this study is to investigate the influence of the exact lens position of LaserLens LB-313 after Femtolaser-Assisted Capsulotomy on the visual performance of the patients
Alcon Research Ltd Safety and Efficacy with Twice Daily Brinzolamide 1% / Brimonidine 0.2% (SIMBRINZA) as an Adjunctive Therapy to Travoprost 0.004% / Timolol 0.5% (DUOTRAV) The purpose of this study is to demonstrate the additive IOP lowering effect of Brinzolamide 1%/Brimonidine 0.2% (dosed BID) when added to Travoprost 0.004%/Timolol 0.5% solution in subjects with open-angle glaucoma or ocular hypertension.
GlaxoSmithKline Research & Development Limited Study 212669: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2798745 in Participants with Diabetic Macular Edema To characterize the safety and tolerability and evaluate the pharmacodynamics of GSK2798745 following 28 days (up to 12 weeks optional) of daily oral dose administration to adult participants with confirmed Diabetic Macular Edema.
Alcon Research Ltd A Prospective, Randomized, Controlled, Multi-Center Clinical Study of the ACRYSOF® IQ Extended Depth of Focus (EDF) IOL The purpose of the study is to demonstrate the safety and performance of the ACRYSOF IQ EDF IOL at Month 3/Visit 4A (70-100 day post 2nd eye implantation)
Alcon Research Ltd A Prospective, Randomized, Controlled, Multi-Center Clinical Investigation of the AcrySof IQ Vivity Extended Vision IOL vs. TECNIS Symfony and AT LARA Extended Depth of Focus IOLs To compare the visual disturbance profile of ACRYSOF VIVITY Extended Vision IOL Model DFT015 with those of diffractice extended depth of focus IOLs
Alcon Research Ltd Clinical Investigation of the Visual Outcomes and Safety of AcrySof® IQ PanOptix® Toric Trifocal IOLs in Asian Population The present study is intended to confirm the effectiveness and safety of the PanOptix Toric Trifocal in Asian population, especially for visual performance.
Alcon Research Ltd Investigation of ACRYSOF® IQ PanOptix™ Presbyopia Correcting IOL Model TFNT00 The objective of this investigation is to describe visual outcomes and assess safety at 12 months (330-420 days) post bilateral implantation of the ACRYSOF IQ PanOptix Presbyopia Correcting IOL
Alcon Research Ltd Clinical investigation of visual function after bilateral implantation of two presbyopia-correcting Trifocal IOLs The purpose of the study is to compare vision at near, intermediate and far distances after the implantation of two Trifocal IOLs
Alcon Research Ltd Qualitative research to modify and evaluate the content validity of two patient-reported outcome measures (APPLES and SILVER) to be used to assess the benefits and harms of IOL implants after cataract surgery The purpose of the study is to develop questionnaires that measure pateints' experience and visual symptoms with the IOLs based on two existing questionnaires, APPLE and SILVER.
Alcon Research Ltd Postmarket Study of outcomes from WaveLight® EX500 InnovEyes™ treatment in conjunction with the InnovEyes™ Sightmap The purpose of the study is to collect additional refractive and visual outcome data from InnovEyes using the InnovEyes sightmap in a post market setting.


ONL Therapeutics A Phase 1b Multicenter, Randomized, Double-Masked, Sham-Controlled Study of the Safety and Tolerability of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma Neuroprotective injection Randomised sham Anx777 fl The purpose of this study is to demonstrate safety and tolerability of ONL1204 Ophthalmic Solution in patients with progressing open angle glaucoma.
Nacuity Pharmaceuticals PTY LTD Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy To evaluate the safety and efficacy of NPI-002 ivt implant compared to control (no implant) in subjects undergoing vitrectomy. Need 5 patients monthly for 9 months
Alcon Research Ltd Contralateral Study of the WaveLight® UV (model 1026) Femtosecond Laser versus the WaveLight® FS200 IR (model 1025) Femtosecond Laser for Corneal Flap Creation This study is being conducted to compare the accuracy of flap creation of the UV-FS Laser versus the already marketed WaveLight® FS200 Laser.

Coming Soon

Alcon Research Ltd Persistence of Iris Landmarks in Various Pupil States This study will collect images of the iris and its landmarks and features in three pupil states.